04.07.2024 • NewsSyensqo

Syensqo and Allozymes to Develop Biosolutions for Home and Personal Care

Belgium-headquartered specialty materials producer Syensqo and Allozymes, a Singaporean enzyme engineering start-up, have signing of a Memorandum of Understanding (MoU) to leverage both companies’ expertise in biotechnology to develop advanced biosolutions for home and personal care, particularly for the skin care market.

Allozymes has developed a proprietary ultra-high throughput microfluidics platform for the engineering of enzymes and microbes which enables the rapid and cost-effective development of biomanufactured ingredients and bioprocesses.

“By combining Allozymes technological capabilities with Syensqo's application and market access expertise, we are poised to create groundbreaking solutions that will not only benefit the home and personal care market but also contribute to a more sustainable future,” said Thomas Canova, head of Renewable Materials & Biotechnology growth platform at Syensqo.

Syensqo said that this MoU marks an important milestone in its strategic agenda of rapidly expanding its beauty specialty ingredients portfolio based on biotechnology and complements the company's recent acquisition of South Korean ceramides specialist JinYoung Bio.

“Our partnership with Syensqo embodies our mutual commitment to a sustainable future, leveraging biotechnology to enable cleaner, greener processes, ensuring our actions today contribute to a healthier planet for future generations. Together, we're setting a new standard for environmental stewardship," commented Peyman Salehian, CEO and co-founder at Allozymes.

© Getty Images
© Getty Images

Company

Syensqo

rue de la Fusée 98
B-1130 Brussels
Belgium

Company contact







CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.